首页> 外文期刊>The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation >The surprising complexity of K-ATP channel biology and of genetic diseases COMMENT
【24h】

The surprising complexity of K-ATP channel biology and of genetic diseases COMMENT

机译:K-ATP通道生物学和遗传疾病的惊人复杂性 评论

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The ATP-sensitive K+ channel (K-ATP) is formed by the association of four inwardly rectifying K+ channel (Kir6.x) pore subunits with four sulphonylurea receptor (SUR) regulatory subunits. Kir6.x or SUR mutations result in K-ATP channelopathies, which reflect the physiological roles of these channels, including but not limited to insulin secretion, cardiac protection, and blood flow regulation. In this issue of the JCI, McClenaghan et al. explored one of the channelopathies, namely Cantu syndrome (CS), which is a result of one kind of K-ATP channel mutation. Using a knockin mouse model, the authors demonstrated that gain-of-function K-ATP mutations in vascular smooth muscle resulted in cardiac remodeling. Moreover, they were able to reverse the cardiovascular phenotypes by administering the K-ATP channel blocker glibenclamide. These results exemplify how genetic mutations can have an impact on developmental trajectories, and provide a therapeutic approach to mitigate cardiac hypertrophy in cases of CS.
机译:ATP 敏感的 K+ 通道 (K-ATP) 由四个向内整流 K+ 通道 (Kir6.x) 孔亚基与四个磺基脲受体 (SUR) 调节亚基结合而成。Kir6.x 或 SUR 突变导致 K-ATP 通道病,这反映了这些通道的生理作用,包括但不限于胰岛素分泌、心脏保护和血流调节。在本期 JCI 中,McClenaghan 等人探讨了其中一种通道病,即 Cantu 综合征 (CS),这是一种 K-ATP 通道突变的结果。使用敲入小鼠模型,作者证明了血管平滑肌中的功能获得性K-ATP突变导致心脏重塑。此外,他们能够通过施用K-ATP通道阻滞剂格列本脲来逆转心血管表型。这些结果举例说明了基因突变如何对发育轨迹产生影响,并提供了一种缓解CS病例心脏肥大的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号